|
ERAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.515700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.635530E-03 |
| Normal-vs-Stage2 |
6.685700E-02 |
| Normal-vs-Stage3 |
3.442000E-03 |
| Normal-vs-Stage4 |
4.976700E-04 |
| Stage1-vs-Stage2 |
6.981500E-04 |
| Stage1-vs-Stage3 |
6.513000E-01 |
| Stage1-vs-Stage4 |
1.925040E-01 |
| Stage2-vs-Stage3 |
6.041300E-04 |
| Stage2-vs-Stage4 |
1.194100E-04 |
| Stage3-vs-Stage4 |
3.921600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.535270E-03 |
| Normal-vs-AfricanAmerican |
1.872250E-01 |
| Normal-vs-Asian |
7.970100E-02 |
| Caucasian-vs-AfricanAmerican |
7.555400E-01 |
| Caucasian-vs-Asian |
5.196400E-01 |
| AfricanAmerican-vs-Asian |
9.360200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.026000E-01 |
| Normal-vs-Female |
1.999400E-03 |
| Male-vs-Female |
3.357600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.636500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.194370E-02 |
| Normal-vs-Age(61-80Yrs) |
5.970400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.650400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.513800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.538000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.257800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.235370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.157200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.509800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.538700E-03 |
| Classical-VS-Follicular |
1.044380E-03 |
| Classical-VS-Other |
3.483800E-01 |
| Classical-VS-Normal |
1.415750E-03 |
| Tall-VS-Follicular |
2.62269999995457E-06 |
| Tall-VS-Other |
9.407000E-01 |
| Tall-VS-Normal |
3.81549999994846E-06 |
| Follicular-VS-Other |
7.476100E-02 |
| Follicular-VS-Normal |
3.928800E-01 |
| Other-VS-Normal |
1.098450E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.590200E-01 |
| Normal-vs-N1 |
9.53830000000044E-05 |
| N0-vs-N1 |
8.247300E-04 |
|
|
